LOAD MORE
You're viewed 9 of 19 products
Dasatinib
General Information
Dasatinib Impurities and Dasatinib
Daicel Pharma synthesizes Dasatinib impurities of exceptional quality, such as Dasatinib Carboxylic Acid, Dasatinib carboxylic acid ethyl ester, Dasatinib impurity-A, Hydroxymethyl Dasatinib, etc. These impurities are crucial to assess the purity, reliability, and safety of Dasatinib, an active pharmaceutical ingredient. Besides, Daicel Pharma provides custom synthesis of Dasatinib impurities to meet clients’ demands for delivery worldwide.
Dasatinib [CAS: 302962-49-8] is an antineoplastic agent that treats chronic myelogenous leukemia (CML) and acute lymphatic leukemia (ALL).
Dasatinib: Use and Commercial Availability
Dasatinib, available under the tradename Sprycel, is a medication for treating different types of leukemia in adult and pediatric patients. It is also effective in treating chronic, accelerated, or blast phase CML when there is resistance or intolerance to prior therapy, including imatinib. Additionally, Dasatinib is used for Ph+ acute lymphoblastic leukemia (ALL) and lymphoid blast CML in cases of resistance or intolerance to prior therapy.
Dasatinib Structure and Mechanism of Action 
The chemical name of Dasatinib is N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazole carboxamide. Its chemical formula is C22H26ClN7O2S, and its molecular weight is approximately 488.0 g/mol.
Dasatinib inhibits multiple tyrosine kinases like BCR-ABL, EPHA2, SRC, etc. It inhibits chronic myeloid leukemia (CML) growth cell lines overexpressing BCR-ABL.
Dasatinib Impurities and Synthesis
Impurities in Dasatinib develop through various pathways, including degradation of the active ingredient, interaction with excipients or impurities in raw materials, and oxidative processes. They can impact the quality, efficacy, and safety of Dasatinib. Analytical methods such as liquid chromatography and mass spectrometry help analyze and identify Dasatinib impurities. The control measures include specifying impurity level limits, implementing good manufacturing practices, and conducting testing, throughout the manufacturing process1. Strict quality control and monitoring ensure that Dasatinib batches comply with regulatory requirements and maintain high purity standards, ultimately ensuring the efficacy and safety of the drug.
Daicel Pharma offers a Certificate of Analysis (CoA) for Dasatinib impurity standards, such as Dasatinib Carboxylic Acid, Dasatinib carboxylic acid ethyl ester, Dasatinib impurity-A, Hydroxymethyl Dasatinib, etc., generated from an analytical facility compliant with cGMP standards. The CoA includes a comprehensive characterization report comprising data from techniques like 1H NMR, 13C NMR, IR, MASS, and HPLC purity. Furthermore, on request, we give additional data like 13C-DEPT and CHN. Daicel Pharma can synthesize unknown Dasatinib impurities or degradation products and labeled compounds to assess the effectiveness of generic Dasatinib. We also offer Dasatinib D4, a deuterium-labeled Dasatinib standard useful in bio-analytical research, such as BA/BE studies. A complete characterization report accompanies every delivery.
References
FAQ's
References
- Das, Jagabandhu; Padmanabha, Ramesh; Chen, Ping; Norris, Derek J.; Doweyko, Arthur M. P.; Barrish, Joel C.; Wityak, John, Cyclic protein tyrosine kinase inhibitors Bristol-Myers Squibb Co., United States, US6979694B2, Dec 27, 2005
- Mhaske, D. V.; Dhaneshwar, S. R., Stability indicating HPTLC and LC determination of dasatinib in pharmaceutical dosage form, Chromatographia, Volume: 66, Issue: 1/2, Pages: 95-102, 2007
Frequently Asked Questions
What are the regulatory requirements for impurity levels in Dasatinib?
Regulatory authorities, such as the United States Pharmacopeia (USP) and the International Conference on Harmonization (ICH), provide guidelines and limits for impurity levels in pharmaceutical products, including Dasatinib.
How are Dasatinib impurities identified and characterized in the drug?
Impurities in Dasatinib are identified and characterized using analytical techniques such as high-resolution mass spectrometry (HRMS) and comparison with reference standards.
What steps help minimize the formation of Dasatinib impurities during the drug synthesis?
The steps to minimize impurity formation during Dasatinib synthesis are optimizing reaction conditions, controlling temperature and pH, using appropriate catalysts and reagents, and implementing effective purification techniques.
What are the temperature conditions required to store Dasatinib impurities?
Dasatinib impurities are stored at a controlled room temperature between 2-8 °C or as indicated on the Certificate of Analysis (CoA).
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.
